Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Jul
21
2015
Federal Circuit Answers Questions About Covered Business Method Review Proceedings Foley & Lardner LLP
Jan
18
2018
How Much Is That Issue Fee Payment In The Window? Foley & Lardner LLP
Aug
18
2015
Sequenom Seeks Rehearing En Banc Foley & Lardner LLP
Feb
27
2018
Pleading a Claim for Misappropriation of Trade Secrets in California: A Problem of Particularity Foley & Lardner LLP
Apr
23
2018
USPTO Issues Patent Eligibility Examination Guidance Under Berkheimer Foley & Lardner LLP
Jul
16
2018
Non-Compete: Who is the Bad Actor? Foley & Lardner LLP
Aug
3
2018
Constitutionality of PTAB Judge Appointments Challenged In Polaris IPR Appeal Foley & Lardner LLP
Nov
16
2015
Federal Circuit To Revisit On Sale Bar Triggered By Contract Manufacture Foley & Lardner LLP
Oct
10
2018
DOJ and FTC Signal Shifts in Antitrust Enforcement of Essential Patent Disputes Foley & Lardner LLP
May
16
2023
Federal Circuit Considers Patentability of Overlapping Ranges Foley & Lardner LLP
Dec
17
2015
Federal Circuit Affirms PTAB's IPR Decision Invalidating A Pharmaceutical Patent Foley & Lardner LLP
Dec
4
2018
PTAB SOP 1 Explains APJ Paneling Process Foley & Lardner LLP
Jun
26
2023
New Framework Proposed for Regulating AI Foley & Lardner LLP
Dec
30
2015
Use of Priority Denial to Subject Apparent "Pre-AIA" Patents to PGR: Inguran v. Premium Genetics Foley & Lardner LLP
Jan
15
2019
Orange Book Listing Creates Injury To Support Standing To Appeal IPR Decision Foley & Lardner LLP
Jan
19
2016
PTAB Denies Challenge Of Abbvie Humira Patents Foley & Lardner LLP
Feb
18
2019
New Estoppel Concern For Petitioners Raised In BTG v. Amneal Foley & Lardner LLP
Mar
4
2019
USPTO Patent Eligibility Training on 2019 Revised Subject Matter Guidance Foley & Lardner LLP
Jan
29
2016
Split Federal Circuit Upholds Constitutionality of Single PTAB Panels Rendering Both Institution & Final Written Decisions Foley & Lardner LLP
Apr
2
2019
Federal Circuit Finds Endo Method Of Treatment Claims Satisfy 35 USC 101 Foley & Lardner LLP
Feb
11
2016
FDA Panel Shows Strong Support for Remicade Biosimilar Foley & Lardner LLP
Nov
9
2023
IP 101 for Emerging Healthy F&B Companies Foley & Lardner LLP
Nov
15
2023
Startup Advisors: How Do Most Startups Get Funded? [Video] Foley & Lardner LLP
Mar
15
2016
PTAB Institutes Kyle Bass IPR Against Pharmaceutical Patent Based On SEC Document Foley & Lardner LLP
Jul
16
2019
Does The U.S. Need STRONGER Patents? Foley & Lardner LLP
Sep
30
2019
Don't Let Your Employees Trade Your Trade Secrets Foley & Lardner LLP
Feb
15
2024
USPTO Warns Against Blind Reliance on Artificial Intelligence Foley & Lardner LLP
May
7
2016
USPTO Releases Patent Eligibility Update Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins